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Series of novel hydrazino-based peptidomimetics and analogues comprising N-terminal lysine and C-terminal 
phenanthridinyl-L-alanine were prepared. Presented results demonstrate up till now unknown possibility to finely 
modulate peptide interaction with DNA/RNA by α-hydrazino group insertion and how different positioning of two α-
hydrazino groups in peptide controls binding to various double stranded and single stranded DNA and RNA. All 
peptidomimetics bind with 1-10 micromolar affinity to ds-DNA/RNA, whereby binding mode is combination of electrostatic 
interactions and hydrophobic interactions within DNA/RNA grooves. Insertion of α-hydrazino group into peptide 
systematically decreased its fluorimetric response to DNA/RNA binding in line: mono-hydrazino<alternating-hydrazino< 
sequential-hydrazino group. Binding studies to ss-polynucleotides suggest intercalation of phenanthridine between 
polynucleotide bases, whereby affinity and fluorimetric response decrease with the number of α-hydrazino groups in 
peptide sequence. Particularly interesting was interaction of two sequential α-hydrazino acids-peptidomimetic with poly 
rG, characterised by specific strong increase of CD bands, while all other peptide/ssRNA combinations gave only CD-bands 
decrease. All mentioned interactions could also be reversibly controlled by pH, due to the protonation of the fluorophore.  
Introduction 
The life is characterised by extremely complex system of 
interactions between proteins, DNA, RNA, and many small 
molecules. These interactions frequently take place at 
structurally well-defined regions formed by protein backbone 
folding. There is a great interest in mimicking folded protein 
epitopes by small molecules,
1,2 
biologically active peptides,
3 
cyclic peptides,
4,5
 or peptidomimetics.
6,7
 While short peptides 
comprising -amino acids generally fail to form 
thermodynamically stable secondary structures, backbone 
extended peptidomimetics comprising - or -amino acids, 
aminoxy or hydrazino acids readily adopt ‘‘protein-like’’ 
secondary structures, such as helices, sheets and turns.
8,9
 -
Peptides and oligomers containing mixtures of - and -amino 
acids have been extensively studied as inhibitors of protein-
protein interactions.
10,11,12
 Replacement of C atom in -amino 
acids with nitrogen leads to hydrazino peptides, a class of 
peptidomimetics characterized by an array of intramolecular 
hydrogen bonds that are responsible for various secondary 
structures.
8,13,14
 Although hydrazino-based peptidomimetics 
showed promising biological activities,
15,16
 their wider 
exploitation is hampered by somewhat challenging synthesis. 
However, it was shown recently by our group and others,
17 
that unprotected hydrazino acids can be successfully applied in 
synthesis of hybrid hydrazino peptidomimetics, thus enabling 
progress in utilization of this class of compounds.  
A number of short natural and synthetic peptides target 
DNA/RNA, among which condensed aromatic-peptide 
conjugates attracted quite a lot of attention in the last 
decade.
18 
In general, condensed-aromatic part contributed to 
DNA/RNA binding by intercalation and was responsible for 
spectrophotometric monitoring of interaction. However, 
selectivity was usually controlled by hydrogen bonding pattern 
along peptide backbone within one of DNA/RNA grooves.
18,19 
To the best of our knowledge, hydrazino acids were never 
incorporated within DNA/RNA targeting compounds, although 
hydrazino moiety is well-directed double hydrogen donor. 
Moreover, incorporation of one or more hydrazino-based 
residues within short peptides can affect peptide secondary 
structure. Acherar et al. found that, owing to the H-bond 
donor and acceptor character of amidic NH, hybrid oligomers 
composed of α-amino and α-hydrazino acids can adopt 
multiple conformations.
14
 We presumed that such 
conformational adaptability could be important for steric 
control and pre-organisation before binding to DNA/RNA. To 
address aforesaid features, we prepared small series of 
hydrazino-based peptidomimetics, 1-4 (Figure 1), whereby 
number and position of -hydrazino residues are 
systematically varied, while keeping constant the position of 
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positively charged lysine (expected to contribute to the 
DNA/RNA binding by electrostatic interactions), and 
fluorescent phenanthridinyl-L-alanine (AlaP) (contributing to 
DNA/RNA binding and reporting the recognition by 
fluorescence). 
Results and discussion 
Synthesis 
Peptides comprising single hydrazino-L-leucine (hLeu) residue 
(2), two sequential hLeu residues (3) and alternating residues 
(4) were prepared by solution-phase methodology. 
Pentapeptide 1 with incorporated AlaP was prepared to 
distinguish contributions of a large condensed aromatic unit 
and hydrazino acids on binding. Generally, peptidomimetics 
were prepared by fragment assembly strategy (Figure 1). 
Tripeptides 5, 7 and 9 were synthesized according previously 
developed methodologies,
1717a
 and coupled to C-terminal 
dipeptide comprising AlaP. In the final step, terminal 
protecting groups were cleaved and crude products purified by 
HPLC.   
 
 
Figure 1. Structures of hydrazino peptides (left) and preparation outline (right): i) HATU, NMM, H-AlaP-OMe in DMF, 24 h, RT; (ii) 
1M NaOH, MeOH, 65 °C, 2 h; (iii) TFA:H2O = 9:1, RT, 1 h; (iv) HATU, NMM, H-Gly-AlaP-OMe in DMF, 24 h, RT; (v) DCC, HOSu, H-
hLeu-OH, in DMF, 24 h, RT. 
Physical-chemical and spectroscopic properties of aqueous 
solutions of 1-4  
Studied compounds 1-4 are soluble in redistilled water (up to c 
= 1  10
-2
 M), and aqueous solutions were stable over 6 
months. Absorbances of 1-4 aqueous solutions were 
proportional to their concentrations up to c = 2-4  10
-5
 M and 
didn’t change notably up to 90 °C, indicating that there is no 
significant inter- or intramolecular aromatic stacking, which 
should give rise to hypochromicity effects. Fluorescence 
emissions of 1-4 were linearly dependent on their 
concentrations up to c = 6  10
-6
 M. Spectroscopic 
characterisation is given in ESI† (Figures S1-S18†). It is 
noteworthy that at pH 5 phenanthridine moiety is mostly 
protonated, which influences to some extent spectroscopic 
properties of 1-4, in line with previous data.
20,21
 Studies of 
interactions with DNA and RNA were done at both, pH 7 and 
pH 5, acidic conditions yielding stronger effects and thus 
discussed in detail within the manuscript.  
DNA/RNA binding studies 
Here used AlaP was previously combined with amino acids (Gly 
and thyminyl-L-alanine, AlaT) and simple dipeptide (Gly-Gly) to 
give moderate binding effects on ds-DNA/RNA thermal 
stability and CD properties.
22
 The incorporation of hydrazino 
acid(s) at various positions in a peptide flanked by lysine on 
one side (for electrostatic attraction with DNA/RNA backbone) 
and by AlaP on opposite side, was expected to have significant 
impact on positioning and binding of phenanthridine 
chromophore to ds-DNA/RNA. Indeed, at both, pH 5 and pH 7, 
1-4 didn’t thermally stabilise any ds-DNA/RNA (Table S1
†
, 
Figures S19-S21
†
). Therefore, intercalative binding mode 
(common for AlaP
2222
) can be excluded. To get better 
structural insight into 1-4 /ds-DNA/RNA complexes, we used 
CD spectroscopy as a highly sensitive method for 
conformational changes in the secondary structure of 
polynucleotides.
23 
Moreover, small molecule chromophores 
(e.g. AlaP in 1-4), could upon binding to DNA or RNA acquire 
induced (I)CD spectrum, which could be helpful in 
determination of binding mode (intercalation, groove binding, 
agglomeration, etc.).
24,25 
However, negligible changes in CD 
spectra of ds-polynucleotides (Figures S23-S34
†
) and absence 
of any induced (I)CD bands > 300 nm, pointed out that 
phenanthridine-chromophore does not bind in one well-
defined orientation in respect to DNA/RNA chiral axis. 
However, fluorimetric response (Figure 2, I in Table 1, Figures 
S51-S54 ESI
†
) and also binding affinity (Ks, Table 1) of 1-4 to ds-
DNA/RNA were both strongly sensitive on the number of 
hydrazino groups in peptide. Even more, peptidomimetic 3 
with two adjacent hydrazino acids showed lower binding 
affinity as well as smaller fluorescence response than 
peptidomimetic 4 with alternating distribution of hydrazino 
acids. Also, binding constants were order of magnitude higher 
at pH 5 (Table 1) than at pH 7 (Table S2 ESI
†
) due to the 
protonation of phenanthridine moiety at acidic conditions, 
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additional positive charge contributing to the electrostatic 
component of binding
2020
. 
 
Figure 2. Experimental () and calculated (–) (by Scatchard eq., Table 1) fluorescence 
intensities of compounds 1-4 upon addition of ct-DNA; note various positions of 
hydrazino-L-leucine (hLeu); Na-cacodylate buffer, pH 5.0, I = 0.05 M, λexc = 310 nm. 
Table 1. Stability constants (logKs)a and spectroscopic properties of complexes I b of 1-
4 with ds-polynucleotides calculated according to fluorimetric titrations (Na-cacodylate 
buffer, c = 0.05 M, pH = 5.0; exc= 310 nm, em= 350 – 500 nm, c(1-4) = 1-2  10
-6 M). 
 ct-DNA 
log Ksa/Ib 
poly (dA-dT)2 
log Ksa / Ib 
poly (dG-dC)2 
log Ksa / Ib 
poly A-poly U 
log Ksa / Ib 
1 6.5 / -78% 6.4 / -80% 6.4 / -81% 5.9 / -75% 
2 6.2 / -55% 6.1 /-61% 6.1 / -62% 5.9 / -38% 
3 5.1 /-20% 5.1 /-21% 4.9 /-35% c 
4 >6d /-12% 6.1 /-24% 5.9 /-34% 5-6d /-15% 
a Processing of titration data by Scatchard equation26 gave values of ratio n [bound 
peptide] / [polynucleotide] = 0.15  0.05 for most complexes; for easier comparison values 
of log Ks are recalculated for fixed n=0.15; correlation coefficients were >0.98-
0.99 for all calculated Ks; b Changes of fluorescence of compound 1-4 induced by 
complex formation (I = (Ilim- I0) 100 / I0 ; where I0 is emission intensity of free 
compound and Ilim is emission intensity of a complex calculated by Scatchard eq.); 
c Too small and linear fluorescence change hampered calculation of Ks; e Small 
total emission change allowed only estimation of Ks. 
All afore mentioned suggests that 1-4 bind externally to ds-
DNA/RNA, whereby binding forces are not exclusively 
electrostatic: two positive charges (Lys and AlaP) should give 
logKs < 4
27
 and only four and more positive charges could yield 
logKs ≥ 6
28
. That supports significant contribution of 
hydrophobic interactions of both, neutral peptide linker and 
also large aromatic fluorophore, whereby better part of the 
molecule is buried within hydrophobic DNA/RNA grooves. 
Hydrophobic binding contribution in combination with various 
steric properties of hydrazino-residues is significant since it 
controls position of fluorophore yielding differences in 
fluorimetric response (1>2>4>3) and binding affinity.  
Comparison of all obtained results revealed that presence of 
N-unsubstituted hLeu impairs the interactions of 2-4 
(compared to 1) by withdrawing the fluorophore from the 
DNA/RNA binding site. When more exposed to water and less 
in binding contact with DNA/RNA, AlaP fluorescence is less 
quenched. The explanation for such outcome can be found in 
conformational preferences of peptides with incorporated -
hydrazino acids, which are able to self-organize through 
intramolecular hydrogen bonding network in solution. For 
instance peptides with N-substituted hydrazino acids show 
“hydrazino-turns”, eight-membered hydrogen-bonded 
pseudocycles.
29,30 
Furthermore,
 
CD spectra of terminally 
protected hydrazino hexamer composed of hLeu and hAla 
resembles structural characteristics of -peptides, namely 
right-handed helical secondary structure.
31
 Acherar et al. 
undertook in-depth secondary structure analysis of oligomers 
composed of alternating -amino acids and N-unsubstituted 
hydrazino acids and reported that the major conformer 
present is in equilibrium between pseudospiranic and 
hydrazino-turn conformation.
14 
Detailed analysis of 1-4/DNA  complexes by structurally more 
informative method like NMR spectroscopy was hampered by 
severe peak overlapping of amide and hydrazino protons 
(similar as noted by Lelais and Seebach
30 
as well as insufficient 
solubility of compound complexes with DNA/RNA.  
Molecular modelling in water of such peptides and their 
DNA/RNA complexes is very demanding task due to the high 
flexibility of peptides and mutual changing of structure upon 
binding; therefore full profile modelling is out of the scope of 
this work. However, in attempt to at least visualise the 
structural features which could explain our experimental 
results, we submitted 1-4 to MM2 calculations by a modified 
version of Allinger's MM2 force field, integrated into the 
ChemBio3D 11.0 programme, whereby obtained structures 
(Figure S65
†
) demonstrate the possible intramolecular H-bond 
network for each peptide, and resulting secondary structure. It 
is noteworthy that structures of 1, 2 overlap excellently 
(Figures S66
†
), as well as the structures of bis-hidrazino 3 and 4 
(Figures S67
†
), however the differences between these two 
groups are substantial. Since compounds 1-4 do not alter ds-
DNA secondary structure (no change in DNA CD spectra, no 
thermal stabilisation), we used as ds-DNA model the 
alternating dAdT-dAdT sequence constructed earlier,
32
 Manual 
docking of 1 and 3 was performed by VMD programme
33
, 
whereby conformational space of small molecule within DNA-
binding site was checked that VdW radii of DNA and ligand do 
not overlap.  
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Scheme 1. Schematic presentation of 1 (up) and 3 (down) manually docked into poly 
dAdT – poly dAdT minor groove. Red lines mark axes positioned along voluminous 
substituents: AlaP and Leu/Lys chains. 
For 1/DNA complex (Scheme 1, up) it is noteworthy that red lines 
positioned along longer axis of AlaP and Leu/Lys chains converge 
into AT-DNA minor groove, giving excellent fit. Hydrophobic area 
(AlaP+Leu) is pointing inside groove, while hydrophilic part (Lys) is 
pointing out. At variance to 1, in 3/DNA (Scheme 1, down) red lines 
positioned along longer axis of AlaP and two hLeu side-chains are 
almost perpendicular, which hampers deep insertion of the 
molecule into AT-DNA minor groove. Consequently, fluorophore 
(AlaP) of 1 (and also analogue 2) could be significantly deeper 
inserted into DNA minor groove, yielding therefore much stronger 
fluorimetric change in comparison to 3 and 4. 
Study of interactions of 1-4 with single stranded (ss) 
polynucleotides 
Single stranded (ss) polynucleotides are considerably more 
flexible than double stranded polynucleotides
3434
. However, it 
should be noted that both poly rA and poly rC can form double 
stranded partially protonated helical structures at pH 5 
(namely poly rAH
+
 - poly rAH
+
 and poly rCH
+
 - poly rC).
34 
Also, 
poly rG can form complex intrastrand structures and actually 
only poly rU can be considered as mostly single stranded at all 
conditions. 
Again, fluorimetric response (Figure 3, I in Table 2 and 
Figure S56-S63 ESI
†
) and also binding affinity (Ks, Table 2) of 1-
4 to ss-RNA were strongly sensitive on the number and 
distribution of hydrazino residues in peptide with similar 
tendency observed for ds-DNA/RNA (Fig. 2). 
  
Figure 3. Experimental () and calculated (–)(by Scatchard eq., Table 2) fluorescence 
intensities of compounds 1-4 upon addition of poly G; values were normalized for 
easier comparison. Na-cacodylate buffer, pH 5.0, I= 0.05 M, λexc = 310 nm.  
Affinities of 1-4 toward single stranded polynucleotides 
were similar at pH 5 (Table 2Table 2) and pH 7 (Table S3 ESI
†
), 
thus not depending on AlaP protonation state. Since aromatic 
stacking interactions are usually not dependent on aryl-charge, 
this suggested intercalation of AlaP between polynucleotide 
bases. That was additionally supported by significantly 
stronger fluorescence quenching of all peptides with poly rA, 
poly rG compared to poly rU, poly rC polynucleotides (Table 
2Table 2), attributed to more efficient aromatic stacking 
interactions between AlaP and larger purine nucleobase in 
respect to smaller pyrimidine. Again, number and vicinity of 
hydrazino groups affects affinities and fluorimetric response in 
line 1>2>4>3 (Figure 3, Figure S56-S63 ESI
†
).  
Table 2. Stability constants (logKs)
a and spectroscopic properties of complexes I b of 1-
4 with ss-polynucleotides calculated according to fluorimetric titrations (Na-cacodylate 
buffer, c = 0.05 M,
 
pH = 5.0; exc= 310 nm, em= 350 – 500 nm, c(1-4) = 1-2  10
-6
 M). 
 poly A 
log Ksa/Ib 
poly G 
log Ksa / Ib 
poly U 
log Ksa / Ib 
poly C 
log Ksa / Ib 
1 5.3 / -64% 5.9 / -98% >6c/ -12% >6c / -19% 
2 5.9 / -42% 6.2 / -82% >5c / -10% >6c / -9% 
3 5.3 / -10% d d d 
4 5-6c / -12% 5.7 /-53% 5-6c / -5% 5-6c / -8% 
a Processing of titration data by Scatchard equation2626 gave values of ratio n [bound 
peptide] / [polynucleotide] = 0.15  0.05 for most complexes; for easier comparison values 
of log Ks are recalculated for fixed n=0.15; correlation coefficients were >0.98-
0.99 for all calculated Ks; b Changes of fluorescence of compound 1-4 induced by 
complex formation (I = (Ilim- I0) 100 / I0 ; where I0 is emission intensity of free 
compound and Ilim is emission intensity of a complex calculated by Scatchard eq.); 
c Small total emission change allowed only estimation of Ks; d Too small and linear 
fluorescence change / no fluorescence change hampered calculation of Ks. 
CD spectropolarimetry was applied for detailed structural 
analysis of complexes
2424,2525
. At acidic conditions (pH 5, 
protonated AlaP) addition of 1-4 resulted in much stronger CD 
response of ss-RNA (Figures 4, 5) in respect to pH 7 (Figures 
S35-S50 ESI
†
), thus only results obtained at pH 5 were further 
discussed.  
Minor decrease within 250-300 nm region could be 
attributed to intercalation of phenanthridine, which should 
yield weak negative ICD band
2525
 around its absorption 
maximum (250 nm, Figure 4) as well as deformation of 
polynucleotide helical structure causing general RNA-CD bands 
decrease.
2323,2525 
Both expected changes could explain the 
observed decrease of CD spectra upon formation of poly rA/1-
4 complexes (Figures S35-38
†
) and poly rG/1,2,4 complexes 
(Figure 4). Also, less pronounced decrease in poly rU and poly 
rC complexes could be attributed to smaller nucleobase size 
and consequently less-efficient aromatic stacking with 
phenanthridine. 
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Figure 4. CD titration of poly G (c = 2  10-5 M) with 1,2,4 at different molar ratios r = 
[compound] / [poly G]. Note isodichroic point in circle. Done at pH = 5.0, sodium 
cacodylate buffer, I = 0.05 M. 
 
Figure 5. CD titration of poly G (c = 2  10-5 M) with 3 at different molar ratios r = 
[compound] / [poly G]. Note isodichroic point in circle. Done at pH = 5.0, sodium 
cacodylate buffer, I = 0.05 M.  
However, as a unique exception, peptidomimetic 3 yielded 
strong increase of all CD bands (Figure 5), whereby isoelliptic 
point in poly rG/3 titration strongly supported formation of 
only one type of a complex.  
Throughout here presented study, 3 showed the lowest 
fluorescence increase for all ds-DNA/RNA and in particularly 
for most ss-RNA, which could be attributed to the rigidity of 
peptide structure due to two sequential hLeu residues. Since 
hydrazino peptides can be considered an extension of -
peptide concept, possible secondary structures of hydrazino 
peptides can be compared with those of -peptides.
35 
It is well 
documented that systematic combination of - and - amino 
acids generates new secondary structures.
36,37,38
 Thus, mixed 
/ peptides were found to adopt various helical secondary 
structures, depending on chirality, structure and distribution of 
two structural units. Generally, introduction of α-amino acid 
increases flexibility as compared with homogeneous βα-
peptides,
3535
 therefore it can be presumed that peptide 3 with 
two sequential hLeu residues is more rigid than 2 and 4 with 
alternating distribution of Leu and hLeu. Thus, observed strong 
CD spectrum increase (Figure 5) could be attributed to the 
switch of the binding mode of poly rG/3 complex, whereby 
phenanthridine is not intercalated (as in other ss-RNA) due to 
steric constrains of two sequential hLeu residues but likely 
positioned along poly rG chain. Such arrangement could 
increase RNA chirality by stabilizing helical structure of 
otherwise not-well organized ss-RNA (thus increasing RNA CD 
bands) and moreover is likely to be combined with strong 
positive ICD band of chromophore (Phen) bound at 
approximately 45
0
 angle to RNA chiral axis.
2525
 The most 
intriguingly, at pH 7 such increase of poly rG CD spectrum by 3 
was much weaker, and didn’t change negative band at 240 nm 
(ESI
†
) pointing out that protonation of phenanthridine plays a 
crucial role, most likely due to electrostatic interactions with 
negatively charged phosphate backbone (another proof of 
non-intercalative binding). 
 
Biology 
While mixed /-peptides are widely exploited for studying 
inhibition of protein-protein interactions (PPI),
3942
 hydrazino-
based peptidomimetics were used to a much lesser extent, 
mainly as human leukocyte elastase and proteasome 
inhibitors,
1515
 or antimicrobial agents.
1616
 Having in mind that 
many PPIs are mediated by small peptides, the use of designed 
peptides and peptidomimetics as modulators of PPI is 
recognized as promising strategy in drug discovery, but also as 
probes to elucidate the role of PPI in cell biology.
43 
 
Phenanthridinium derivatives are often strongly cytotoxic, 
which renders their applications as dyes in biochemical studies 
on DNA and RNA.
44
 Short peptides also could show 
considerable cell toxicity. However, both, phenanthridine 
analogues
45
 and peptides are also studied as powerful 
anticancer drugs. For that reason we screened compounds 1, 2 
and 4 for cytotoxic activity against two adenocarcinoma cell 
lines: cervix (HeLa) and colon (CaCo-2), chronic myeloid 
leukaemia in blast crisis (K562), and normal epithelial cell line 
(MDCK1) as well. Results pointed out negligible activity of all 
studied peptidomimetics (ESI
†
, S64
†
) that reached growth 
inhibition by 50 % (GI50) just on K562 cells at concentration 
near or higher than 10
-4
 M. Such low cytotoxicity makes these 
fluorescent peptides safe dyes for laboratory applications.  
Conclusions 
Hydrazino peptidomimetics 1-4 were prepared to study 
systematically the impact of hydrazino-L-leucine (hLeu) residue 
in short peptide sequence linking two common DNA/RNA-
interacting moieties: positively charged lysine at the peptide 
N-terminal part and phenanthridinyl-L-alanine (AlaP) at the 
peptide C-terminal part, acting as pH-dependent fluorophore.  
Comparison of results obtained for 1-4 with those reported 
previously for dipeptides Gly-AlaP and thyminyl-L-alanyl-
phenanthridinyl-L-alanine (AlaT-AlaP)
2222
 revealed that N-
terminal peptide part has a great influence on binding mode. 
Already Lys-Leu-Leu-Gly sequence in 1 caused switch of 
binding ds-DNA/RNA mode from intercalation, reported for 
Gly-AlaP and AlaT-AlaP
2222
, to external binding combined with 
polynucleotide groove interaction. Moreover, replacement of 
leucine with hydrazino analogues, their number and 
distribution along peptide backbone determined binding to ds-
DNA/RNA, which was proportionally reported by quenching of 
AlaP fluorescence in line: 2 (single hLeu) > 4 (two alternating 
hLeu) > 3 (two sequential hLeu). In addition, all peptides 
retained moderate (1-10µM) affinity toward ds-DNA/RNA, 
externally controllable by pH (due to AlaP protonation) by 
change in order of magnitude. Intriguingly, peptides 1-4 
showed high affinity toward ss-RNA (comparable to ds-
DNA/RNA). Again, fluorimetric response of AlaP was 
proportional to the number of hLeu in peptide sequence,.i.e. 
emission quenching tendency decrease in line 1>2>4>3.  
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However, the most interesting was specific binding of the 
peptide 3 with two sequential hLeu to poly rG, which caused 
unique super-organisation of poly rG characterised by specific 
response in CD spectrum. In addition, CD response at 240 nm 
(negative band attributed to poly rG backbone) was observed 
only at pH 5 but not pH 7, and thus could be switched on and 
off by non-destructive external stimuli (pH). Such specific 
spectrophotometric probe for micromolar concentrations of 
poly rG is to the best of our knowledge not known. 
Presented results demonstrate up till now untired 
possibility to finely modulate peptide interaction with 
DNA/RNA by α-hydrazino-group insertion and moreover 
combination of several α-hydrazino-groups within peptide. 
Given results (along with non-toxicity of these 
peptidomimetics) encourage further studies in line with 
combination of multiple α-hydrazino-groups within peptide to 
completely abolish ds-DNA/RNA binding and still preserve high 
ss-DNA/RNA affinity with particular emphasis on specific poly 
G recognition achieved by 3. This future research would 
directly address very limited number of small molecules highly 
selective or specific toward ss-DNA/RNA sequences, whereby 
they found intriguing biomedical uses, for instance in antiviral 
and antitumor applications.
46,47 
Although there are examples 
of peptides binding to ss-DNA48, Intriguingly, ss-RNA were 
strongly underexploited targets, most likely due to larger 
variety of biologically available forms.
49,50 
Experimental section 
Materials and methods 
Reactions were monitored by TLC on Silica Gel 60 F254 plates 
(Merck; Darmstadt, Germany) using detection with ninhydrin. 
Column chromatography was performed on Silica Gel (Merck, 
0.040–0.063). RP HPLC analysis was performed on HPLC 
system coupled with UV detector; C-18 semipreparative (250 9 
8 mm, ID 5 m) column at flow rate of 1 mL/min, or analytical 
(150 9 4.5 mm, ID 5 m) column at flow rate of 0.5 mL/min. UV 
detection was performed at 254 nm or 270 nm. NMR spectra 
were recorded on 600 and 300 MHz spectrometers, operating 
at 150. 92 or 75.47 MHz for 13C and 600.13 or 300.13 MHz for 
1H nuclei. TMS was used as an internal standard. Mass 
spectrometry measurements were performed on HPLC system 
coupled with triple quadrupole mass spectrometer, operating 
in positive electrospray ionization (ESI) mode. Spectra were 
recorded from a 10 g/mL compound solution in 50 % 
MeOH/0.1 % FA by injection of 3 L into the ion source of the 
instrument by autosampler, at the flow rate of 0.2 mL/min 
(mobile phase 50 % MeOH/0.1 % FA). HRMS analysis was 
performed on MALDI-TOF mass spectrometer operating in 
reflectron mode. Mass spectra were acquired by accumulating 
three spectra after 400 laser shots per spectrum. Calibrant and 
analyte spectra were obtained in positive ion mode. 
Calibration type was internal with calibrants produced by 
matrix ionization (monomeric, dimeric and trimeric CHCA), 
with azithromycin and angiotensin II dissolved in -cyano-4-
hydroxycinnamic acid matrix in the mass range m/z 190.0499 
to 749.5157 or 1046.5417. Accurately measured spectra were 
internally calibrated and elemental analysis was performed on 
Data Explorer v. 4.9 Software with mass accuracy better than 5 
ppm. Samples were prepared by mixing 1 L of analyte 
methanol solution with 5 L of saturated (10 mg/mL) solution 
of -cyano-4-hydroxycinnamic acid (-CHCA) and internal 
calibrants (0.1 mg/mL) dissolved in 50 % acetonitrile/0.1 % 
TFA. MM2 calculations were performed by a modified version 
of Allinger’s MM2 force field, integrated into the 
ChemBioOffice 2008 programme. Compounds 3, 5, 7 and 9 
were prepared according previously developed procedure.
17a 
All measurements were performed in aqueous buffer solution 
(pH = 5, I = 0.05 M, sodium cacodylate/HCl buffer or pH = 7, I = 
0.05 M, sodium cacodylate/HCl buffer). The UV-Vis spectra 
were recorded on a Varian Cary 100 Bio spectrometer in 
quartz cuvettes (1 cm). Fluorescence spectra were recorded on 
Varian Cary Eclipse fluorimeter in quartz cuvettes (1 cm). 
Under the experimental conditions used (~ 10-6 M) the 
absorbance and fluorescence intensities of 1-4 were 
proportional to their concentrations. 
Polynucleotides were purchased as noted: poly dGdC – poly 
dGdC, poly dAdT – poly dAdT, poly A – poly U, poly A, poly G,  
poly U, poly C (Sigma), calf thymus (ct)-DNA (Aldrich) and 
dissolved in sodium cacodylate buffer, I = 0.05 M, pH=7. The 
calf thymus ctDNA was additionally sonicated and filtered 
through a 0.45 mm filter.
51 
Polynucleotide concentration was 
determined spectroscopically
52
 as the concentration of 
phosphates. The concentration of the stock solution (10 mM) 
of single stranded poly A at pH 7 was determined by UV 
absorbance measurement at 258 nm using a molar extinction 
coefficient () value of 9800 M
-1
 cm
-1
 and it was expressed as 
the concentration of phosphates. It is important to note that 
at experimental conditions (pH = 5) poly A and poly C were 
protonated and formed double helix. The double-stranded 
conformation of poly A and poly C was obtained by lowering 
the pH value from the initial value of 7.0 to 5.0 and their 
concentrations directly derived from the concentration of 
single stranded polynucleotides (ss-poly A). The formation of 
ds-poly A and ds-poly C were confirmed by CD and thermal 
melting experiments.
53,54
 
In fluorimetric experiments, excitation wavelengths at max ≥ 
305 nm were used in order to avoid absorption of excitation 
light by added polynucleotides. Fluorimetric titrations were 
performed by adding portions of polynucleotide solution into 
the solution of the studied compound (c= 210
-6
 M). After 
mixing polynucleotides with studied compounds it was 
observed in all cases that equilibrium was reached in less than 
120 seconds. In following 2-3 hours fluorescence spectra of 
complexes remained constant. Fluorescence spectra were 
collected at r < 0.3 (r = (compound) / (polynucleotide)) to 
assure one dominant binding mode. Data that were processed 
by means of Scatchard equation
2626
 gave values of ratio n 
[bound compound] / [polynucleotide] in the range 0.07-0.2, 
but for easier comparison all Ks values were re-calculated for 
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fixed n=0.15. Calculated values for Ks have satisfactory 
correlation coefficients (>0.99). 
CD spectra were recorded on JASCO J815 spectrophotometer 
at room temperature using appropriate 1 cm path quartz 
cuvettes with scanning speed of 200 nm/min. Buffer 
background was subtracted from each spectra, while each 
spectra was result of three accumulations. CD experiments 
were performed by adding portions of compound stock 
solution into the solution of polynucleotide (c = 1-210
-5
 M). 
Thermal melting experiments were performed on a Varian 
Cary 100 Bio spectrometer in quartz cuvettes (1 cm). The 
measurements were done in aqueous buffer solution at pH 5 
or pH 7 (sodium citrate/HCl buffer I = 0.03 M). Thermal melting 
curves for ds-DNA, ds-RNA and their complexes with 1-4 were 
determined by following the absorption change at 260 nm a 
function of temperature.
55,56
 Absorbance scale was 
normalized. Tm values are the midpoints of the transition 
curves determined from the maximum of the first derivative 
and checked graphically by the tangent method. The Tm 
values were calculated subtracting Tm of the free nucleic acid 
from Tm of the complex. Every Tm value here reported was 
the average of at least two measurements. The error in Tm is 
 0.5 °C. 
Synthetic procedures 
Boc-Lys(Boc)-Leu-Leu-Gly-AlaP-OMe (4) 
Boc-Lys(Boc)-Leu-Leu-Gly-OH (3) (32 mg, 0.051 mmol) was 
dissolved in dry DMF, NMM (8 μL, 0.051 mmol) and HATU (22 
mg, 0.056 mmol) were added and reaction was stirred at room 
temperature. After 15 min solution of H-AlaP-OMe (20 mg, 
0.051 mmol) and NMM (8 μL, 0.051 mmol) in 2 mL dry DMF 
was added. Reaction was stirred at room temperature 
overnight. Solvent was evaporated and the residue purified by 
the flash column chromatography in EtOAc:petrol ether:EtOH 
3:1:0.5. 
Yield: 54 % (25 mg). Yellow oil. Rf 0.77 (EtOAc:petrol 
ether:EtOH 3:1:0.5). Mr 906.12. ESI-MS: m/z 906.5 [M+H]
+
. 
1
H 
NMR (600 MHz, CD3OD): δ 7.63–7.56 (m, 7H Har AlaP), 4.89 (m, 
1H,  AlaP), 4.10 (m, 1H,  Lys), 3.96–3.82 (m, 2H,  Leu
2
, 
Leu
3
,), 3.74 (s, 2H,  Gly), 3.35 (s, 3H, OCH3), 3.06 (m, 2H, β 
AlaP), 3.03 (m, 2H,  Lys), 1.73–1.55 (m, 10H, β, Lys, β, Leu
2
, 
Leu
3
), 1.45–1.42 (m, 18H, CH3 Boc), 1.33 (m, 2H,  Lys), 0.99–
0.94 (m, 6H, ,' Leu
2
), 0.90–0.84 (m, 6H, ,' Leu
3
). 
H-Lys-Leu-Leu-Gly-AlaP-OH (1) 
Compound 4 (46 mg 0.051 mmol) was dissolved in 5 mL of 
methanol and 1M NaOH (105 µL, 0.105 mmol) was added. 
Reaction was stirred under reflux for 2 h. Solvent was 
evaporated, residue dissolved in water, acidified to pH 3 by 10 
% citric acid and product extracted with EtOAc. After solvent 
evaporation, residue was dissolved in 0.5 mL of TFA-H2O 
mixture (9:1, v/v) and the reaction was stirred at room 
temperature for 1h. Solvent was evaporated and product 
purified by RP-HPLC. HPLC conditions: Eurospher 100 RP C-18 
column 250 × 4.5 mm, i.d. 5 μm; flow rate = 1 mL/min;  = 270 
nm; mobile phase: 0 min 40 % B, 0-20 min 40 % B-90 % A, 20-
30 min 90 % B, 30-35 min 90 % B-40 % B. A = 0.1 % TFA in 
water, B = 0.1 % TFA in MeOH.  
Yield: 67 % (12 mg). Colorless oil. Rt 19.0 min. Mr 691.86. ESI-
MS: m/z 346.8 [M+H]
2+
, m/z 692.4 [M+H]
+
. 
1
H NMR (600 MHz, 
CD3OD): δ 8.94 (d, J = 8.6 Hz, 1H), 8.49 (d, J = 7.5 Hz, 1H), 8.51 
(m, 1H), 8.21 – 8.16  (m, 2H), 8.00 (d, J = 7.0 Hz, 1H), 7.96 (d, J 
= 6.3 Hz, 1H), 4.93 (m, 1H), 4.47 (m, 1H), 4.33–4.24 (m, 1H), 
3.95 (m, 1H), 3.90–3.78 (dd, 
2
J = 16.9 Hz 2H), 3.38 (s, 3H), 3.36 
(s, 2H), 2.99 (m, 2H), 1.91 (m, 2H), 1.78–1.69 (m, 4H), 1.64 (m, 
3H), 1.58–1.48 (m, 3H), 1.00–0.86 (m, 12H). 
13
C NMR (151 
MHz, CD3OD): δ 174.9, 174.7, 174.2, 171.2, 170.0, 162.8, 
141.1, 138.8, 138.5, 134.3, 133.7, 133.2, 132.2, 130.4, 125.8, 
125.5, 125.9, 124.6, 54.7, 53.9, 53.7, 53.4, 43.2, 41.7, 41.4, 
40.2, 38.6, 32.0, 28.0, 25.8, 25.7, 23.4, 23.2, 22.4, 22.0, 21.8, 
20.2.   HRMS (MALDI-TOF/TOF): calcd. for C37H53N7O6 M+H
+
 
692.4130; found 692.415. 
Boc-Lys(Boc)-hLeu-Leu-Gly-AlaP-OMe (6) 
Compound 5 (85 mg, 0.14 mmol) was dissolved in dry DMF, 
NMM (15 μL, 0.14 mmol) and HATU (58 mg, 0.15 mmol) were 
added. After 15 min solution of H-Gly-AlaP-OMe (65 mg, 0.14 
mmol) and NMM (15 μL, 0.14 mmol) in 1 mL dry DMF was 
added. Reaction was stirred at room temperature overnight. 
Solvent was evaporated and the residue purified by flash 
column chromatography in EtOAc:petrol ether:EtOH 3:1:0.5. 
Yield: 22 % (28 mg). Yellow oil. Rf 0.7 (EtOAc:petrol ether:EtOH 
3:1:0.5). Mr 921.13. ESI-MS: m/z 921.8 [M+H]
+
. 
1
H NMR (600 
MHz, CD3OD): δ 8.69 (m, 2H), 8.38 (m, 2H), 8.08 (d, J = 8.3 Hz, 
1H), 7.48 (dd, 
2
J = 8.4 Hz, 2H), 4.94 (m, 1H), 3.92 (m, 1H), 3.89–
3.81 (m, 1H), 3.78–3.74 (m, 2H), 3.57–3.50 (m, 1H), 3.45–3.32 
(m, 2H), 2.99 (s, 3H), 2.86 (s, 3H), 2.85–2.82 (m, 2H), 1.84 (m, 
2H), 1.74–1.67 (m, 3H), 1.62–1.55 (m, 3H), 1.53–1.47 (m, 2H), 
1.47–1.38 (m, 18H), 1.18–1.09 (m, 2H), 1.00–0.80 (m, 12H). 
H-Lys-hLeu-Leu-Gly-AlaP-OH (2) 
Compound 6 (60 mg 0.07 mmol) was dissolved in 5 mL of 
methanol and 1M NaOH (130 µL; 0.13 mmol) was added. 
Reaction was stirred under reflux 2 h. Solvent was evaporated, 
residue dissolved in water, acidified to pH 3 by 10% citric acid 
and product extracted with EtOAc. After solvent evaporation, 
residue was dissolved in 0.5 mL of TFA-H2O mixture (9:1, v/v) 
and the reaction was stirred at room temperature for 1h. 
Solvent was evaporated and product purified by RP-HPLC. 
HPLC-conditions: Eurospher 100 RP C-18 column 250 × 4.5 
mm, i.d. 5 μm; flow rate = 1 mL/min;  = 270 nm; mobile 
phase: 0 min 50 % B, 0-20 min 50 % B-90 % A, 20-30 min 90 % 
B, 30-35 min 90 % B-50 % B. A = 0.1 % TFA in water, B = 0.1 % 
TFA in MeOH. 
Yield: 10 % (5 mg). Colorless oil. Rt 16.7 min. Mr 706.87. ESI-
MS: m/z 707.3 [M+H]
+
. 
1
H NMR (600 MHz, CD3CN): δ 8.83–8.78 
(m, 2H), 8.42 (m, 1H), 8.38 (m, 1H), 8.15 (d, J = 8.3 Hz, 1H), 
7.97–7.93 (m, 2H), 7.66 (m, 2H), 7.60 (d, J = 8.8 Hz, 1H), 7.50 
(m, 2H), 4.80 (m, 1H), 4.34 (m, 2H), 3.88 (s, 2H), 3.56–3.54 (m, 
1H), 3.32 (m, 2H), 2.95 (s, 3H), 1.68 (m, 2H), 1.65 (m, 2H), 1.57 
(m, 2H), 1.53 (m, 2H), 1.46 (m, 2H), 1.34–1.32 (m, 2H), 0.97–
0.93 (m, 12H). 
13
C NMR (151 MHz, CD3CN): δ 176.3, 175.3, 
171.2, 169.2, 169.2, 161.1, 160.9, 140.6, 138.7, 137.5, 137.2, 
133.9, 132.1, 131.3, 130.5, 125.4, 125.2, 124.4, 64.4, 54.6, 
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52.9, 51.9, 41.2, 40.4, 40.2, 37.7, 37.5, 30.9, 26.7, 25.8, 25.7, 
23.2, 23.1, 22.4, 21.9, 21.5, 21.4. HRMS (MALDI-TOF/TOF): 
calcd. for C37H54N8O6 M+H
+
 707.4239; found 707.4252. 
Boc-Lys(Boc)-hLeu-hLeu-Gly-AlaP-OMe (8) 
Compound 7 (80 mg, 0.13 mmol) was dissolved in dry DMF, 
NMM (15 μL 0.13 mmol) and HATU (54 mg, 0.13 mmol) were 
added. After 15 min solution of H-Gly-AlaP-OMe (60 mg, 0.13 
mmol) and NMM (15 μL, 0.13 mmol) in 1 mL dry DMF was 
added. Reaction was stirred at room temperature overnight. 
Solvent was evaporated and the residue purified by flash 
column chromatography in EtOAc:petrol ether:EtOH 3:1:0.5. 
Yield: 11 % (14 mg). Yellow oil. Rf = 0.82 (EtOAc:petrol 
ether:EtOH 3:1:0.5). Mr 936.15. ESI-MS: m/z 937.9 [M+H]
+
. 
1
H 
NMR (300 MHz, CD3OD): δ 8.74 (m, 1H), 8.27–8.00 (m, 1H), 
7.93–7.30 (m, 5H), 4.97 (m, 1H), 4.25 (m, 1H), 4.19–3.90 (m, 
1H), 3.88–3.75 (m, 1H), 3.74–3.41 (m, 2H), 3.40 (s, 3H), 3.20–
2.88 (m, 4H), 2.87 (s, 3H), 2.07–1.54 (m, 8H), 1.48 (m, 18H), 
1.45–1.29 (m, 4H), 1.10–0.86 (m, 12H, ,' hLeu). 
H-Lys-hLeu-hLeu-Gly-AlaP-OH (3) 
Compound 8 (50 mg, 0.05 mmol) was dissolved in 5 mL 
methanol and 1M NaOH (110 µL, 0.11 mmol) was added. 
Reaction was stirred under reflux for 2 h. Solvent was 
evaporated, residue dissolved in water, acidified to pH 3 by 10 
% citric acid and product extracted with EtOAc. After solvent 
evaporation, residue was dissolved in 0.5 mL of TFA-H2O 
mixture (9:1, v/v) and the reaction was stirred at room 
temperature for 1h. Solvent was evaporated and product 
purified by RP-HPLC. HPLC conditions: Eurospher 100 RP C-18 
column 250 × 4.5 mm, i.d. 5 μm; flow rate = 1 mL/min;  = 270 
nm; mobile phase:  0 min 50 % B, 0-20 min 50 % B-90 % A, 20-
30 min 90 % B, 30-35 min 90 % B-50 % B. A = 0.1 % TFA in 
water, B = 0.1 % TFA in MeOH.  
Yield: 13 % (5 mg). Colorless oil. Rt 18.1 min. Mr 721.89. ESI-
MS: m/z 722.5 M+H
+.
 
1
H NMR (600 MHz, CD3CN): δ 8.74 (m, 
2H, 8.31 (d, J = 5.3 Hz, 1H), 8.02 (d, J = 8.5 Hz, 1H), 7.20 (m, 
3H), 6.65 (s, 1H), 4.82 (m, 1H), 3.77–3.70 (m, 1H), 3.68 (m, 2H), 
3.54–3.49 (m, 2H), 3.32 (m, 2H), 3.26 (s, 3H), 2.54 (m, 2H), 2.04 
(m, 2H), 1.87–1.80 (m, 2H), 1.63 (m, 2H), 1.56–1.50 (m, 2H), 
1.38–1.32 (m, 4H), 0.89–0.86 (m, 12H). 
13
C NMR (151 MHz, 
CD3CN): δ 178.1, 172.1, 171.4, 170.9, 170.1, 162.8, 141.1, 
138.8, 138.5, 134.3, 134.1, 133,7, 133.2, 132.8, 131.9, 130.4, 
125.8, 125.7, 124.0, 124.6, 66.3, 63.9, 57.8, 53.6, 43.5, 41.3, 
40.1, 38.6, 33.8, 29.6, 25.6, 24.8, 22.8, 22.1, 22.0, 21.9, 20.2. 
HRMS (MALDI-TOF/TOF): calcd. for C37H55N9O6 M+H
+
 
722.4348; found 722.4349. 
Boc-Lys(Boc)-hLeu-Leu-hLeu-Gly-AlaP-OMe (10) 
Boc-Lys(Boc)-hLeu-Leu-hLeu-OH (45 mg, 0.063 mmol) was 
dissolved in dry DMF, NMM (7 μL, 0.063 mmol) and HATU (26 
mg, 0.069 mmol) were added. After 15 min solution H-Gly-
AlaP-OMe (30 mg, 0.063 mmol) and NMM (7 μL, 0.063 mmol) 
in 1 mL dry DMF was added. Reaction was stirred at room 
temperature overnight. Solvent was evaporated and the 
residue purified by flash column chromatography in eluents 
EtOAc:petroleum ether:EtOH=3:1:0.5. 
Yield: 61 % (40 mg). Yellow oil. Rf = 0.78 (EtOAc:petroleum 
ether:EtOH=3:1:0.5). Mr 1049.31. ESI-MS: m/z 1050 [M+H]
+
. 
H-Lys-hLeu-Leu-hLeu-Gly-AlaP-OH (4) 
Compound 9 (40 mg, 0.038 mmol) was dissolved in 5 mL 
methanol and 1M NaOH (286 µL, 0.286 mmol) was added. 
Reaction was stirred under reflux for 12 h. Solvent was 
evaporated, residue dissolved in water, acidified to pH 3 by 10 
% citric acid and product extracted with EtOAc. After solvent 
evaporation, residue was dissolved in 0.5 mL of TFA-H2O 
mixture (9:1, v/v) and the reaction was stirred at room 
temperature for 1h. Solvent was evaporated and product 
purified by RP-HPLC. HPLC conditions: Eurospher 100 RP C-18 
column 250 × 4.5 mm, i.d. 5 μm; flow rate = 1 mL/min;  = 270 
nm; mobile phase: 0 min 50 % B, 0-20 min 50 % B-90 % A, 20-
30 min 90 % B, 30-35 min 90 % B-50 % B. A = 0.1 % TFA in 
water, B = 0.1 % TFA in MeOH  
Yield: 10 % (3 mg). Colourless oil. Rt 23.8 min. Mr 835.05. ESI-
MS: m/z 835.6 M+H
+
. 
1
H NMR (600 MHz, CD3OD): δ 8.97 (m, 
1H), 8.79 (m, 1H), 8.51 (dd, J = 8.4 Hz, 1H), 8.27–7.99 (m, 3H), 
7.56 (d, 
2
J = 8.4 Hz, 1H), 4.91 (m, 1H), 4.49–4.42 (m, 1H), 4.14–
4.06 (m, 1H), 3.64 (m, 2H), 3.39 (s, 5H), 3.01 (m, 2H), 2.99–2.91 
(m, 2H), 2.01 (m, 2H), 1.93–1.88 (m, 2H), 1.78–1.75 (m, 3H), 
1.68–1.59 (m, 12H), 1.53–1.50 (m, 2H), 0.98–0.93 (m, 18H). 
13
C 
NMR (151 MHz, CD3CN): δ 178.2, 172.3, 171.6, 170.7, 170.3, 
170.1, 162.8, 141.2, 138.7, 138.6, 134.3, 133.9, 132.5, 131.8, 
130.4, 125.8, 125.5, 125.1, 124.7, 124.6, 66.3, 63.7, 57.6, 57.3, 
55.4, 53.5, 43.7, 41.2, 40.1, 39.8 38.6, 33.5, 32.8, 29.6, 25.8, 
25.5, 24.8, 24.6, 22.7, 22.4, 22.2, 21.7, 20.3. HRMS (MALDI-
TOF/TOF): calcd. for C43H66N10O7 M+H
+
 835.5188; found 
835.5199.  
Cytotoxicity evaluation 
Cytotoxic effects on the normal and tumors cells’ growth were 
determined using the colorimetric methyltetrazolium (MTT) assay. 
Experiments were carried out on three tumor human cell lines 
(HeLa, CaCo-2, and K562) and on one canine cell line (MDCK I) as 
normal cells. The adherent cells, MDCK1, HeLa, and CaCO2, were 
seeded in 96 micro-well plates at a concentration of 2×10
4
 cells/mL 
and allowed to attach overnight in the CO2 incubator (IGO 150 
CELLlife
TM
, JOUAN, Thermo Fisher Scientific, Waltham, MA, USA). 
After 72 hours of exposure to tested compounds, medium was 
replaced with 5 mg/mL MTT solution and the resulting formazane 
crystals were dissolved in DMSO. Leukemia cells at a concentration 
of 1x10
5
 cells ⁄ mL, were plated onto 96 micro-well plates and after 
72 hours of incubation, 5mg/mL MTT solution was added to each 
well and incubated 4 hours in CO2 incubator. To each well, 10% SDS 
with 0.01 mol ⁄ L HCl was added to dissolve water-insoluble MTT-
formazane crystals overnight. Elisa micro plate reader (iMark, BIO 
RAD, Hercules, CA, USA) was used for measurement of absorbance 
at 595nm. All experiments were performed at least three times in 
triplicates. The percentage of cell growth (PG) was calculated using 
the following equation: 
PG= (A compound – A background /A control – A background) X100 
where Abackground at the adherent cells is absorbance of MTT 
solution and DMSO; Abackground at the suspension cells is the 
absorbance of the medium without cells, but containing MTT 
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and 10%SDS with  0.01 mol/L HCl; and Acontrol is the absorbance 
of cell suspension grown without tested compounds. 
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